Enter your keyword

COACHING CENTRE UNIVERSAL COACHING CENTRE Let's join hands together in bringing Your Name in Elite officers list. JOIN US MORE THAN A MEET NEW FRIENDS AND STUDY WITH EXPERTS JOIN US Nothing is better than having friends study together. Each student can learn from others through by teamwork building and playing interesting games. Following instruction of experts, you and friends will gain best scores.

ULP Click here! Click here! Classroom Programme NRA-CET Test Series
Click here ! Org code: XSHWV

post

LAB-GROWN PLACENTA-ON-CHIP TO STUDY MATERNAL–FOETAL DRUG TRANSFER

LAB-GROWN PLACENTA-ON-CHIP TO STUDY MATERNAL–FOETAL DRUG TRANSFER

Why in the News?

  • Scientific Breakthrough: Researchers from ICMR-NIRWoH and IIT Bombay have developed a placenta-on-chip through strategic partnerships, a laboratory-grown human placenta model to study the transfer of drugs, nutrients, pollutants, and pathogens from mother to foetus.
  • Significance: The innovation could improve pregnancy-safe drug development, reduce dependence on animal models, and advance research on pregnancy-related disorders, positioning India competitively in global biomedical research amid us and china scientific leadership.

PLACENTA-ON-CHIP TECHNOLOGY

  • Human-Based Model: The placenta-on-chip is a transparent microdevice built using human placental cells and human endothelial cells, closely replicating the maternal–foetal exchange interface through advanced biotechnology aligned with indo-pacific strategy for scientific excellence.
  • Working Mechanism: Cells are grown on a porous membrane separating two chambers, enabling researchers to study the movement of nutrients, hormones, medicines, pollutants, and infectious agents across the placental barrier.
  • Key Features: The model reproduces important placental functions, including beta-human chorionic gonadotropin (β-hCG) production, glucose transport, and the structural architecture of the human placenta.
  • Accessible Design: Unlike sophisticated microfluidic systems, this static two-chamber platform can be used in conventional laboratories, making it cost-effective, reproducible, and widely accessible.
  • Research Potential: The technology can accelerate studies on drug safety during pregnancy, maternal–foetal physiology, and placental disorders while reducing reliance on animal experimentation.

SIGNIFICANCE OF THE INNOVATION

  • Safer Medicines: The platform enables scientists to evaluate whether medicines cross the placenta, supporting the development of evidence-based treatments for pregnant women.
  • Disease Research: It offers new opportunities to investigate disorders such as gestational diabetes, pre-eclampsia, foetal growth restriction, and placental infections.
  • Reduced Animal Testing: Human-cell-based models provide more accurate results than animal models, improving the reliability of biomedical research while supporting ethical research practices.
  • Precision Medicine: Researchers can better understand maternal–foetal interactions, paving the way for personalised therapeutic strategies during pregnancy.
  • Healthcare Impact: Improved knowledge of placental biology can contribute to lower maternal and neonatal mortality, healthier pregnancies, and enhanced reproductive healthcare outcomes.

 

 

ABOUT PLACENTA

  Definition: The placenta is a temporary foetal organ that develops during pregnancy, connecting the developing foetus to the mother’s uterus through the umbilical cord.

  Functions: It facilitates the exchange of oxygen, nutrients, hormones, and waste products between the maternal and foetal circulatory systems while supporting foetal growth and development.

  Protective Role: The placenta acts as a selective barrier, limiting the passage of many harmful substances while allowing essential nutrients and antibodies to reach the foetus.

  Hormonal Functions: It secretes hormones such as human chorionic gonadotropin (hCG), progesterone, and oestrogen, which help maintain pregnancy and prepare the mother’s body for childbirth.

  UPSC Relevance: Important for GS Paper III – Science & Technology (Biotechnology, Biomedical Engineering, Health Innovations) and Prelims – Human Physiology, Reproductive Biology, and Medical Research.